Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cellular Goods' products to launch on Chill.com

15 Nov 2023 07:00

RNS Number : 4567T
Cellular Goods PLC
15 November 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

15 November 2023

 

Cellular Goods plc

 

("Cellular Goods" or "The Company")

 

Cellular Goods to launch its products on the Chill.com marketplace in the UK and USA

 

Cellular Goods (LSE: CBX), a UK based company pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions, is pleased to announce its partnership with Chill Brands Group PLC and the forthcoming launch of its 'Look Better' skincare range on the online platform, Chill.com, to expand UK and US awareness and distribution of its premium next-generation wellness products.

 

Chill Brands Group PLC's online platform, Chill.com, is an online shop for wellness and relaxation products, providing an authentic selection of hemp, nootropics and other functional ingredients to help its customers feel more relaxed and refreshed. Designed to provide an effective route to market for its selected products, Chill.com is focused on the UK and US markets.

 

The full Cellular Goods 'Look Better' skincare range will be listed for purchase on Chill.com including the best-selling Rejuvenating Face Serum, Rejuvenating Night Cream and Nourishing Face Oil which are all powered by the company's breakthrough anti-inflammatory, CBG. CBG has been shown to prevent inflammation in the skin, known to accelerate skin ageing, without the side effects associated with industry-standard ingredients retinol and vitamin C.

 

Cellular Goods' products will be available on the Chill.com ecommerce website in advance of the busy holiday shopping period.

 

Darcy Taylor, Interim CEO at Cellular Goods, commented: "Cellular Goods is continuing to improve market awareness and distribution of the 'Look Better' skincare range in our latest partnership with Chill Brands Group PLC. As the anchor skincare tenant with the online shop for wellness and relaxation products, our listing on Chill.com will help build on Cellular Goods' profile and sales in the UK and US and broaden our accessibility to customers. This partnership marks another milestone in our strategy to build momentum and activate efficient distribution of the 'Look Better' high-end skincare range, delivering revenue growth and long-term shareholder value."

 

Callum Sommerton, CEO of Chill Brands Group PLC said: "We are very pleased to welcome Cellular Goods to Chill.com and look forward to introducing their innovative CBG product range to our US and UK audiences. The continuously expanding range of natural wellness products available on our platform is intended to improve how people look, feel, think and rest - so I am confident that these new additions from Cellular Goods will be a great fit."

 

For further information please contact:

 

Cellular Goods

Darcy Taylor

Chairman and Interim CEO

via FSCF +44 7572 873 300

First Sentinel Corporate Finance (FSCF)

Investor Relations

Rebecca Noonan

IR@cellular-goods.com

Media Relations

Rebecca Noonan

Media@cellular-goods.com

Corporate Broker & Advisor

Brian Stockbridge

 

+44 7572 873 300

 

 

+44 7572 873 300

 

 

+44 7858 888 007

Novum Securities

 

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427 

 

About Cellular Goods PLC:

Cellular Goods is pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions. The Company launched with a focus on efficacy led and science-backed products utilising biosynthetics, and now employs its expertise across two verticals: premium next-generation cannabinoid skincare products, and carbon sequestration-as-a-service through its wholly owned business division, King Tide Carbon, which utilises biosynthetic algae and seaweed to provide scalable carbon removal. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com.

 

 

About Chill.com

Chill.com is an online marketplace focused on the growing health and wellness space. The site, which is owned and operated by Chill Brands Group PLC, markets highly differentiated, quality products made from natural ingredients to an engaged consumer base in the US and UK. From supplements and skincare essentials to nootropics and alcohol alternatives, the site provides a new sales channel and distribution outlet to some of the world's most exciting emerging brands.For more information visit www.chill.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCVZLFFXFLZFBX
Date   Source Headline
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSDirectorate change
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20222:05 pmRNSSecond Price Monitoring Extn
14th Mar 20222:00 pmRNSPrice Monitoring Extension
14th Mar 20227:00 amRNSLaunch of outdoor marketing campaign
8th Mar 202211:03 amRNSShare purchase by CEO
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:00 amRNSExercise of Warrants
1st Mar 20227:00 amRNSLaunch of Rejuvenating Cannabinoid Face Serum
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20222:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:01 pmRNSPrice Monitoring Extension
21st Feb 202211:05 amRNSSecond Price Monitoring Extn
21st Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20229:05 amRNSSecond Price Monitoring Extn
21st Feb 20229:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSStrategy and trading update
2nd Feb 20227:00 amRNSWhite paper on cannabinoids and skin aging
7th Jan 20221:00 pmRNSResults of Annual General Meeting
15th Dec 20217:00 amRNSAnnual General Meeting update
8th Dec 20217:00 amRNSGrant of Options to CEO
6th Dec 20211:57 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSAppointment of new CEO
3rd Dec 20217:00 amRNSAnnual results
1st Dec 20217:00 amRNSLaunch of inaugural products & ecommerce platform
11th Nov 20217:00 amRNSAdvertising and PR agencies appointed
8th Nov 20212:05 pmRNSSecond Price Monitoring Extn
8th Nov 20212:00 pmRNSPrice Monitoring Extension
8th Nov 202111:05 amRNSSecond Price Monitoring Extn
8th Nov 202111:00 amRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSGrant of Share Options and update on warrants
4th Oct 20219:06 amRNSSecond Price Monitoring Extn
4th Oct 20219:00 amRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSDirector dealings & TR1 notification
16th Aug 20217:00 amRNSSupply agreement signed with Chanelle McCoy Health
2nd Aug 20217:00 amRNSShare disposal by significant shareholder
28th Jul 20212:06 pmRNSSecond Price Monitoring Extn
28th Jul 20212:00 pmRNSPrice Monitoring Extension
10th Jun 20217:00 amRNSSupply agreement signed with Willow Biosciences
25th May 20217:00 amRNSCellular Goods Interim Results
6th May 20217:00 amRNSGrant of Warrants and Extension of Exercise Period
20th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSCellular Goods boosts team with five appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.